The role of microRNAs in COVID-19 with a focus on miR-200c

Objective: Epigenetics is a quickly spreading scientific field, and the study of epigenetic regulation in various
diseases such as infectious diseases is emerging. The microribonucleic acids (miRNAs) as one of the
types of epigenetic processes bind to their target messenger RNAs (mRNAs) and regulate their stability and/
or translation. This study aims to evaluate non-coding RNAs (ncRNAs) with a focus on miR-200c in COVID-19.
In this review, we first define the epigenetics and miRNAs, and then the role of miRNAs in diseases focusing
on lung diseases is explained. Finally, in this study, we will investigate the role and position of miRNAs
with a focus on miR-200c in viral and severe acute respiratory syndrome–related coronavirus (SARS-CoV2)
infections.
Methods: Systematic search of MEDLINE, PubMed, Web of Science, Embase, and Cochrane Library was conducted
for all relative papers from 2000 to 2021 with the limitations of the English language. Finally, we selected 128 articles
which fit the best to our objective of study, among which 5 articles focused on the impact of miR-200c.
Results: Due to the therapeutic results of various drugs in different races and populations, epigenetic processes,
especially miRNAs, are important. The overall results showed that different types of miRNAs can be effective on
the process of various lung diseases through different target pathways and genes. It is likely that amplified levels
of miR-200c may lead to decreased angiotensin-converting enzyme-2 (ACE2) expression, which in turn may
increase the potential of infection, inflammation, and the complications of coronavirus disease.
Conclusion: miR-200c and its correlation with ACE2 can be used as early prognostic and diagnostic markers.